VelosBio Competitors and Similar CompaniesClear all

Partner Therapeutics's competitors and similar companies include OS Therapies, Andarix Pharmaceuticals and OncoHost.
Partner Therapeutics
Partner Therapeutics
Partner Therapeutics is developing and commercializing cancer medicines and combination therapies.
OS Therapies
OS Therapies
OS Therapies (OST) is a therapeutic company focused on identifying, developing, and commercializing treatments for osteosarcoma.
Andarix Pharmaceuticals
Andarix Pharmaceuticals
Andarix Pharmaceuticals is a company developing and commercializing novel cancer therapies that are targeted to the patients most likely to respond.
OncoHost
OncoHost
OncoHost is a clinical-stage precision oncology company that develops a host response profiling platform (PROphetTM) for cancer therapies.
Founding Date
Founding Date
2017
Founding Date
2018
Founding Date
N/A
Founding Date
2017
Type
Type
Private
Type
Public
Type
Private
Type
Private
Tags
Locations
Locations
Lexington, US HQ
Boston, US
Lynnwood, US
Locations
Rockville, US HQ
Locations
HQ
Locations
Binyamina-Giv'at Ada, IL HQ
Employees
Employees
189
Employees
4
Employees
N/A
Employees
562% decrease

Funding

Latest funding round
Latest funding round
$ 60m (over 8 years ago)
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 35m (about 4 years ago)
Total funding raised
Total funding raised
$ 60m
Total funding raised
$ 6m
Total funding raised
N/A
Total funding raised
$ 43m
For sources of this data, please see the company profile

View Company Profiles

OS Therapies
HQ
Rockville, US
Employees
4

OS Therapies (OST) is a therapeutic company focused on identifying, developing, and commercializing treatments for osteosarcoma.

View company
Andarix Pharmaceuticals
HQ

Andarix Pharmaceuticals is a company developing and commercializing novel cancer therapies that are targeted to the patients most likely to respond.

View company
OncoHost
HQ
Binyamina-Giv'at Ada, IL
Employees
56↓ 2% decrease

OncoHost is a clinical-stage precision oncology company that develops a host response profiling platform (PROphetTM) for cancer therapies.

View company